Search Results Search Sort by RelevanceMost Recent Viewpoint Dec 2019 Genome Editing, Ethics, and Politics Isabel Gabel, PhD and Jonathan Moreno, PhD Genome editing raises old questions, but CRISPR arose in a political landscape that vastly differs from the early aughts. AMA J Ethics. 2019;21(12):E1105-1110. doi: 10.1001/amajethics.2019.1105. In the Literature Feb 2001 Sources of Embryonic Stem Cells for Research Faith Lagay, PhD Virtual Mentor. 2001;3(2):35-36. doi: 10.1001/virtualmentor.2001.3.2.jdsc1-0102. Case and Commentary Oct 2008 Physician and Parental Decision Making in Newborn Resuscitation, Commentary 2 Frank A. Chervenak, MD and Laurence B. McCullough, PhD Virtual Mentor. 2008;10(10):620-624. doi: 10.1001/virtualmentor.2008.10.10.ccas1-0810. Case and Commentary Sep 2013 Weighing Risks and Benefits of Prescribing Antidepressants during Pregnancy Benjamin C. Silverman, MD and Anne F. Gross, MD Virtual Mentor. 2013;15(9):746-752. doi: 10.1001/virtualmentor.2013.15.9.ecas1-1309. Case and Commentary Oct 2009 The Patient Who Says He Is Ready to Die Margaret Tarpley, MLS and John Tarpley, MD Virtual Mentor. 2009;11(10):761-765. doi: 10.1001/virtualmentor.2009.11.10.ccas3-0910. Viewpoint Jun 2012 What Can Physicians Learn from the Neurodiversity Movement? Christina Nicolaidis, MD, MPH The neurodiversity movement challenges us to rethink autism through the lens of human diversity, valuing diversity in neurobiologic development as we would value it in gender, race, ethnicity, religion, or sexual orientation. Virtual Mentor. 2012;14(6):503-510. doi: 10.1001/virtualmentor.2012.14.6.oped1-1206. State of the Art and Science Oct 2019 Should Clinicians Leave “Expanded” Carrier Screening Decisions to Patients? Amanda Fakih, MHSA and Kayte Spector-Bagdady, JD, MBE Testing everyone for everything identifies more fetal conditions, but confusion persists about whether clinicians should leave screening decisions to patients. AMA J Ethics. 2019;21(10):E858-864. doi: 10.1001/amajethics.2019.858. Case and Commentary Dec 2020 What Should We Do When Families Refuse Testing for Brain Death? Robert D. Truog, MD, MA, Wynne Morrison, MD, MBE, and Matthew Kirschen, MD, PhD Two commentaries respond to a case about apnea testing to confirm death by neurologic criteria. AMA J Ethics. 2020;22(12):E986-994. doi: 10.1001/amajethics.2020.986. In the Literature Jun 2019 Disentangling Evidence and Preference in Patient-Clinician Concordance Discussions Leah Z. G. Rand, DPhil and Zackary Berger, MD, PhD How should evidence be used to interpret and inform whether to accommodate patients’ requests for clinicians with specific traits? AMA J Ethics. 2019;21(6):E505-512. doi: 10.1001/amajethics.2019.505.